The prevalence of type 2 diabetes is rising worldwide, especially in older adults. Diet and
lifestyle, particularly plant-based diets, are effective tools for type 2 diabetes prevention and …

Human studies have established a positive association between the intake of industrial trans
fatty acids and the development of cardiovascular diseases, leading several countries to …

Gut microbiota is involved in obesity, metabolic syndrome and the progression of
nonalcoholic fatty liver disease (NAFLD). It has been recently suggested that the flavonoid …

The majority of people with type 2 diabetes are overweight or obese, and weight loss is a
recommended treatment strategy. A systematic review and meta-analysis was undertaken to …

Metabolic syndrome (MetS), today a major global public health problem, is a cluster of
clinical, metabolic, and biochemical abnormalities, such as central adiposity, hypertension …

Obesity represents a major risk factor for a plethora of severe diseases, including diabetes,
cardiovascular disease, non-alcoholic fatty liver disease, and cancer. It is often …

The growing awareness of the adverse health effects of trans‐fats and saturated fats are
driving researchers to seek healthy alternatives. A promising strategy to structure liquid oil …

This review deals with the effects of synthetic and natural fatty acids on the biophysical
properties of membranes, and on their implication on cell function. Natural fatty acids are …

INTRODUCTION Obesity and its associated complications are serious global concerns.
Despite growing public health initiatives, obesity rates continue to rise. Thus, there is a …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and
leading cause of cirrhosis in the United States and developed countries. NAFLD is closely …